Ehlers–Danlos syndrome

Published on 05/05/2015 by admin

Filed under Internal Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1252 times

133 Ehlers–Danlos syndrome

Advanced-level questions

What do you know about Ehlers–Danlos syndrome?

It comprises a group of heterogeneous disorders that result from defects in collagen synthesis and vary genetically and clinically from one another (Science 1973;182:298). Some molecular defects are known.

Type VI (kyphoscoliotic type). The most common and autosomal recessive form of inheritance. There is a defect in the enzyme lysyl hydroxylase, which is necessary for hydroxylation of lysyl residues during collagen synthesis. Only collagen types 1 and 3 are affected, and collagen types 2, 4 and 6 are normal. The predominant clinical features are ocular fragility with rupture of the cornea and retinal detachment. Some of these patients respond to ascorbic acid.

Type IV (‘vascular type’). This is caused by a defect in the structural gene for collagen type 3 (COL3A1) and is inherited as an autosomal dominant trait. As type 3 collagen is present largely in blood vessels and intestines, the typical features of this syndrome include easy bruising; thin skin with visible veins; characteristic facial features; rupture of the large arteries, uterus or colon; and reduced life expectancy. This is the most severe form of Ehlers–Danlos syndrome (N Engl J Med 2000;342:673–80). Loeys–Dietz syndrome overlaps with this type.

Type VII. A defect in the conversion of procollagen to collagen, caused by the mutation that affects one of the two type 1 collagen genes (COL1A1 and COL1A2). Although in the single mutant allele, only 50% of type 1 collagen chains are affected, heterozygotes manifest the syndrome because these abnormal chains interfere with the formation of normal collagen helices.

Type IX. This is caused by a defect in copper metabolism, with high levels of copper in the cells but low levels of serum copper and caeruloplasmin. Because the gene influencing copper metabolism is on the X chromosome, it is inherited as an X-linked recessive trait. This disease illustrates how copper metabolism can affect connective tissue.

Classical or types I and II. Null alleles of the COL5A1 gene encoding type V collagen are a cause of the classical form. A single base mutation in COL5A2 causes type II. Mutations in a gene that encodes tenascin-X, which is neither a collagen nor a collagen-modifying protein, can result in a variation of the classic form of the Ehlers–Danlos syndrome.

Notes

Patients with type I, II and IV disease are often investigated for bleeding diathesis before the correct diagnosis is made. Because of joint instability and laxity, many patients with types I, II, III, VI and VII disease are investigated for developmental delay before it is recognized that they have this syndrome.

Over 35 collagen genes have now been identified and these encode the chains of >20 types of collagen: types 1, 2 and 3 are the interstitial or fibrillar collagen whereas types 4, 5 and 6 are amorphous and are present in the interstitial tissue and basement membranes.